Fluoxetine capsules, indicated for the treatment of premenstrual dysphoric disorder are the generic version of Eli Lilly’s Sarafem Pulvules capsules.
Currently, Mylan has 112 abbreviated new drug applications (ANDA) pending FDA approval, 23 of which are potential first-to-file opportunities.